Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2015, Article ID 964392, 5 pages
http://dx.doi.org/10.1155/2015/964392
Research Article

Preoperative Peripheral Blood Count in Breast Carcinoma: Predictor of Prognosis or a Routine Test

1Department of Surgery, GGS Medical College, Faridkot 151203, India
2Department of Pathology, GGS Medical College, Faridkot 151203, India

Received 25 July 2015; Revised 8 November 2015; Accepted 11 November 2015

Academic Editor: Vladimir F. Semiglazov

Copyright © 2015 Amrit Pal Singh Rana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, R. Nye, and W. C. Levy, “Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE),” Journal of the American College of Cardiology, vol. 41, no. 11, pp. 1933–1939, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Grimm Jr., J. D. Neaton, and W. Ludwig, “Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality,” The Journal of the American Medical Association, vol. 254, no. 14, pp. 1932–1937, 1985. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Aliustaoglu, A. Bilici, B. B. O. Ustaalioglu et al., “The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment,” Medical Oncology, vol. 27, no. 4, pp. 1060–1065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Korde, J. A. Zujewski, L. Kamin et al., “Multidisciplinary meeting on male breast cancer: summary and research recommendations,” Journal of Clinical Oncology, vol. 28, no. 12, pp. 2114–2122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Akinbami, A. Popoola, A. Adediran et al., “Full blood count pattern of pre-chemotherapy breast cancer patients in Lagos, Nigeria,” Caspian Journal of Internal Medicine, vol. 4, no. 1, pp. 574–579, 2013. View at Google Scholar · View at Scopus
  6. C. Gómez-Raposo, F. Z. Tévar, M. S. Moyano, M. L. Gómez, and E. Casado, “Male breast cancer,” Cancer Treatment Reviews, vol. 36, no. 6, pp. 451–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Parkin, F. I. Bray, J. Ferlay, and P. Pisani, “Estimating the world cancer burden. Globocan 2000,” International Journal of Cancer, vol. 94, no. 2, pp. 153–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Gascon and PJ. Barret-Lee, “Prevalence of anemia in cancer patients not receiving antineoplastic treatment (ANT): data from the European Cancer Anaemia Survey (ECAS),” Journal of Clinical Oncology, vol. 24, supplement, article 185, 2006. View at Google Scholar
  9. A. Shankar, J. J. Wang, E. Rochtchina, M. C. Yu, R. Kefford, and P. Mitchell, “Association between circulating white blood cell count and cancer mortality. A population-based cohort study,” Archives of Internal Medicine, vol. 166, no. 2, pp. 188–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. P. Erlinger, P. Muntner, and K. J. Helzlsouer, “WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey Mortality Study,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 6, pp. 1052–1056, 2004. View at Google Scholar · View at Scopus
  11. H. W. Bruckner, P. T. Lavin, S. C. Plaxe, J. A. Storch, and E. M. Livstone, “Absolute Granulocyte, lymphocyte, and monocyte counts. useful determinants of prognosis for patients with metastatic Cancer of the stomach,” Journal of the American Medical Association, vol. 247, no. 7, pp. 1004–1006, 1982. View at Publisher · View at Google Scholar · View at Scopus
  12. R. T. Chlebowski, I. Silverberg, T. Pajak, J. Weiner, C. Kardinal, and J. R. Bateman, “Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil. Prognostic aspects of the differential white blood cell count,” Cancer, vol. 45, no. 9, pp. 2240–2244, 1980. View at Publisher · View at Google Scholar
  13. J. S. Blake-Mortimer, S. E. Sephton, R. W. Carlson, D. Stites, and D. Spiegel, “Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer,” Breast Journal, vol. 10, no. 3, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Shamshad Ahmad, K. Akhtar, A. K. Verma, A. Z. Mallik, and S. A. Siddqui, “Total peripheral lymphocyte count in malignant tumors: an index of prognostication,” Journal of Medical Sciences, vol. 12, no. 1, pp. 24–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. T. N. Lee, “Peripheral lymphocyte count and subpopulations of T and B lymphocytes in benign and malignant diseases,” Surgery Gynecology and Obstetrics, vol. 144, no. 3, pp. 435–450, 1977. View at Google Scholar · View at Scopus
  16. L. F. Porrata and S. N. Markovic, “Is absolute lymphocyte count just another prognostic factor in cancer?” SRX Medicine, vol. 2010, Article ID 812304, 8 pages, 2010. View at Publisher · View at Google Scholar
  17. F. Balkwill and L. M. Coussens, “Cancer: an inflammatory link,” Nature, vol. 43, pp. 1405–1406, 2004. View at Google Scholar
  18. T. Nemoto, T. Han, J. Minowada, V. Angkur, A. Chamberlain, and L. Dao, “Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells,” Journal of the National Cancer Institute, vol. 53, no. 3, pp. 641–645, 1974. View at Google Scholar · View at Scopus
  19. A. Sasaki, S. Kai, Y. Endo et al., “Prognostic value of preoperative peripheral blood Monocyte count in patients with colorectal liver metastasis after liver resection,” Journal of Gastrointestinal Surgery, vol. 11, no. 5, pp. 596–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ikeda, H. Furukuwa, H. Imamura et al., “Poor prognosis associated with thrombocytosis in patients with gastric cancer,” Annals of Surgical Oncology, vol. 9, no. 3, pp. 287–291, 2002. View at Publisher · View at Google Scholar
  21. J. T. Kerpsack and M. A. Finan, “Thrombocytosis as a predictor of malignancy in women with a pelvic mass,” Journal of Reproductive Medicine, vol. 45, no. 11, pp. 929–932, 2000. View at Google Scholar · View at Scopus
  22. H. Shimada, G. Oohira, S.-I. Okazumi et al., “Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma,” Journal of the American College of Surgeons, vol. 198, no. 5, pp. 737–741, 2004. View at Publisher · View at Google Scholar · View at Scopus